- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/565 - IFN-beta
Patent holdings for IPC class C07K 14/565
Total number of patents in this class: 255
10-year publication summary
|
31
|
15
|
14
|
26
|
21
|
21
|
19
|
21
|
19
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Orionis Biosciences BV | 79 |
14 |
| The Regents of the University of California | 20694 |
12 |
| Orionis Biosciences Inc. | 108 |
12 |
| Modernatx, Inc. | 1289 |
10 |
| Abion Inc. | 68 |
9 |
| Biogen MA Inc. | 937 |
8 |
| Universiteit Gent | 1399 |
8 |
| Vib VZW | 901 |
8 |
| East Carolina University | 170 |
7 |
| Ubiprotein, Corp. | 12 |
7 |
| Mayo Foundation for Medical Education and Research | 3377 |
6 |
| CytomX Therapeutics, Inc. | 231 |
5 |
| Glytech, Inc. | 62 |
5 |
| Rutgers, The State University of New Jersey | 1972 |
5 |
| Idemitsu Kosan Co., Ltd. | 4228 |
4 |
| Ares Trading S.A. | 249 |
4 |
| The Brigham and Women's Hospital, Inc. | 2282 |
4 |
| Immunwork Inc. | 26 |
4 |
| Tilt Biotherapeutics Oy | 31 |
4 |
| Allozyne, Inc. | 7 |
3 |
| Other owners | 116 |